Bionano Genomics, Inc. Stock Analysis & AI Score
Bionano Genomics, Inc. (BNGO) has an ST Score of 58.1 (B-), driven by its Valuation (A+) and held back by its Profitability (D-). Analysts rate it Buy with a $46.50 price target (+3319.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIBNGO Stock Price History
BNGO Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
BNGO Latest Stock News
ST Score
Bionano Genomics, Inc. (BNGO) has an ST Score of 58.1 (B-), driven by its Valuation (A+) and held back by its Profitability (D-). Analysts rate it Buy with a $46.50 price target (+3319.1% upside).
- Strongest
- ValuationA+
- Weakest
- ProfitabilityD-
All factor grades
- ValuationA+
- ForecastA
- GrowthB+
- MomentumB-
- Financial StrengthC+
- ProfitabilityD-
- Piotroski4/9
Press Releases
Company Contact Details
BNGO stock: frequently asked questions
What is BNGO's ST Score?
Bionano Genomics, Inc. (BNGO) has an ST Score of 58.1 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BNGO a buy, hold, or sell?
Analysts rate BNGO a Buy, with a price target of $46.50 (+3319.1% vs the current price). Our ST Score grades it B- (58.1/100). The ST Score is a data-driven signal, not a recommendation.
What are BNGO's factor grades?
Valuation A+, Profitability D-, Financial Strength C+, Momentum B-, Growth B+, Forecast A.
What is BNGO's valuation grade?
Bionano Genomics, Inc. (BNGO) earns a valuation grade of A+, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BNGO's growth grade?
Bionano Genomics, Inc. (BNGO) earns a growth grade of B+, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BNGO's profitability grade?
Bionano Genomics, Inc. (BNGO) earns a profitability grade of D-, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BNGO's financial strength grade?
Bionano Genomics, Inc. (BNGO) earns a financial strength grade of C+, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BNGO?
The average analyst price target for Bionano Genomics, Inc. (BNGO) is $46.50 from 7 analysts, which is +3319.1% versus the recent price of $1.36.
What is BNGO's Piotroski score?
Bionano Genomics, Inc. (BNGO) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.